Back to results
US 2020/0048339 A1Published application
Use of il-20 antagonists for treating eye diseases
AssigneeNational Cheng Kung University
InventorMing-Shi CHANG
Life of this patent
Estimating the term…
Abstract
Methods for treating eye diseases such as dry eye disease (DED) and age-related macular degeneration (AMD) using an IL-20 antagonist that blocks the signaling pathway mediated by IL-20, for example, an antibody that binds IL-20 or an IL-20 receptor.
Claims21
A method for treating or delaying the onset of an eye disease in a subject, the method comprising administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising an IL-20 antagonist.
Dependencies are inferred from the claim text.